Iradimed (IRMD) Other Non-Current Assets (2013 - 2026)
Iradimed's (IRMD) quarterly Other Non-Current Assets came in at $244000.0 in Q2 2026, up 19.32% year-over-year from $204499.0 in Q2 2025, and up 8.44% quarter-over-quarter from $225000.0 in Q1 2026.
Analysis
Iradimed (IRMD) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Iradimed (IRMD) has reported Other Non-Current Assets for 14 consecutive years, with $244000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 19.32% year-over-year to $244000.0 in Q2 2026; TTM through Jun 2026 was $244000.0, a 19.32% increase from a year earlier, with the FY2025 full-year figure at $239000.0, down 32.49% from the prior year.
- Other Non-Current Assets was $244000.0 for Q2 2026 at Iradimed, up from $225000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $648672.0 in Q4 2022 and troughed at $172272.0 in Q1 2022.
- A 5-year average of $256484.6 and a median of $210191.5 in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 222.2% in 2022 and tumbled 72.03% in 2023, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $648672.0 in 2022, then plunged by 72.03% to $181449.0 in 2023, then jumped by 95.1% to $354000.0 in 2024, then plunged by 32.49% to $239000.0 in 2025, then climbed by 2.09% to $244000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $244000.0 (Q2 2026), $225000.0 (Q1 2026), and $239000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | 244,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244,000.00 |
| Mar 31, 2026 | 225,000.00 |
| Dec 31, 2025 | 239,000.00 |
| Sep 30, 2025 | 214,374.00 |
| Jun 30, 2025 | 204,499.00 |
| Mar 31, 2025 | 206,009.00 |
| Dec 31, 2024 | 354,000.00 |
| Sep 30, 2024 | 184,213.00 |
| Jun 30, 2024 | 188,235.00 |
| Mar 31, 2024 | 184,701.00 |
| Dec 31, 2023 | 181,449.00 |
| Sep 30, 2023 | 177,663.00 |
| Jun 30, 2023 | 252,161.00 |
| Mar 31, 2023 | 502,953.00 |
| Dec 31, 2022 | 648,672.00 |
| Sep 30, 2022 | 236,188.00 |
| Jun 30, 2022 | 201,334.00 |
| Mar 31, 2022 | 172,272.00 |
| Dec 31, 2021 | 201,325.00 |
| Sep 30, 2021 | 225,749.00 |